An Advanced Protocol-Driven Transition from Parenteral Prostanoids to Inhaled Trepostinil in Pulmonary Arterial Hypertension

Patients with pulmonary arterial hypertension (PAH) often require parenteral prostanoids to improve symptoms and signs of PAH. Complications of parenteral prostanoids-such as catheter-related infections and intolerable adverse effects-may develop, prompting transition to inhaled prostanoids. We repo...

Full description

Bibliographic Details
Main Authors: Oudiz, Ronald, Agarwal, Manyoo, Rischard, Franz, De Marco, Teresa
Other Authors: Univ Arizona, Coll Med, Dept Pulm Crit Care & Sleep Med
Language:en
Published: UNIV CHICAGO PRESS 2016
Subjects:
Online Access:http://hdl.handle.net/10150/622493
http://arizona.openrepository.com/arizona/handle/10150/622493